Remove 2010 Remove Litigation Remove Patent Application
article thumbnail

Product Patents and Process Patents: Analysing the MHC’s Insights in the cases of Kyorin and Frito-Lay

SpicyIP

Balaji of the Madras High Court (MHC) delivered two decisions that overturned the Controller’s rejection of patent applications, siding with the appellants in both cases. Bitter Pill to Swallow: Controller’s Decision Overturned for Kyrorin’s Patent Application The first one is Kyorin Pharmaceutical Co v.

Patent 105
article thumbnail

Defending Design Patents

Patently-O

In our new paper, The Truth About Design Patents , we debunk three widely held—but incorrect—views about U.S. design patents. Taken together, these myths paint a grim picture of design patents: Half of all design patent applications are rejected. Most asserted design patents are invalidated in litigation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CAFC Says University of Minnesota Patent Fails Written Description Test

IP Watchdog

The Board thus concluded that the patent would not guide a skilled artisan to the patent’s claims. The CAFC agreed with the PTAB’s decision and with the ruling that a 2010 patent application publication filed by Gilead was “prior art” over the university’s patent.

Patent 69
article thumbnail

Guest Post: DABUS Gains Traction: South Africa Becomes First Country to Recognize AI-Invented Patent

Patently-O

They include such issues as whether (and how) Dr. Thaler obtained authorization from DABUS to file the patent application, and whether the patent statutes include a requirement that inventors be human. Each of these three jurisdictions found sufficient reasons in these formalities to reject DABUS’ patent applications.

Invention 128
article thumbnail

Jab We Met (if at all): Do Patent Oppositions and Examination Run on a Parallel track? Delhi High Court to Examine

SpicyIP

Background Natco had filed a pre-grant opposition in 2016 against Novartis’ IN 414518 patent application. After multiple rounds of to-and-fro amendments, written submissions, and other applications, the patent application finally was limited to 8 claims on 6th June 2020. In Neon Labs v.

Patent 102
article thumbnail

Supreme Court Declines to Weigh in on Notice Required to Trigger Statute of Limitations for Trade Secret Misappropriation Claims

LexBlog IP

The case arises out of a 2018 lawsuit, in which four self-described inventors of DNA Arrays brought suit against Illumina, a “multibillion-dollar, global player in genetic analysis,” alleging that Illumina and its associates conspired to steal Petitioner’s trade secrets and covertly conceal the information in patent applications.

article thumbnail

Patent Eligibility Jurisprudence

Patently-O

Additionally, if you are a patent owner or inventor, please include the number of U.S. and foreign patent applications you have filed; the number of U.S. Patent prosecution strategy and portfolio management; b. patent enforcement and litigation; c. patent counseling and opinions; d. employment; f.

Patent 102